NextTrip, Inc. — Director's Dealing 2021

Aug 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SIGMA LABS, INC. (SGLB)
CIK: 0000788611
Period of Report: 2021-08-11

Reporting Person: Fisher Ronald Kenneth Jr (VP of Business Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-11	Stock Option (right to buy)	$3.42	A	30313	Acquired	2026-08-11	Common Stock (30313.00)	Direct
2021-08-11	Stock Appreciation Right	$3.42	A	30313	Acquired	2026-08-11	Common Stock (30313.00)	Direct

Footnotes

F1: The stock option will vest and become exercisable as follows: (i) 25% of the option vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the option will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

F2: The stock appreciation right ("SAR") is payable in cash only, and vests as follows: (i) 25% of the SAR vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the SAR will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.